Search

Author/Creator Hortobagyi, Gabriel N.

1. Breast Cancer Subtype and Baseline Characteristics from Diabetic Breast Cancer Patients are Not Different from Nondiabetics. Issue 4 (26th May 2014)

Authors:
Campos‐Gomez, Saúl; Valero, Vicente; Flores‐Arredondo, Jose Humberto; Isassi‐Chapa, Adolfo; Rangel‐Rodríguez, Ignacio; Hortobagyi, Gabriel N.; Gonzalez‐Angulo, Ana Maria
Journal:
Breast journal
Issue:
Volume 20:Issue 4(2014:Jul./Aug.)
Page Start:
434
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. (14th March 2017)

Authors:
Giuliano, Armando E.; Connolly, James L.; Edge, Stephen B.; Mittendorf, Elizabeth A.; Rugo, Hope S.; Solin, Lawrence J.; Weaver, Donald L.; Winchester, David J.; Hortobagyi, Gabriel N.
Journal:
CA
Issue:
Volume 67:Number 4(2017:Jul./Aug.)
Page Start:
290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update. Issue 35 (10th December 2021)

Authors:
Moy, Beverly; Rumble, R. Bryan; Come, Steven E.; Davidson, Nancy E.; Di Leo, Angelo; Gralow, Julie R.; Hortobagyi, Gabriel N.; Yee, Douglas; Smith, Ian E.; Chavez-MacGregor, Mariana; Nanda, Rita; McArthur, Heather L.; Spring, Laura; Reeder-Hayes, Katherine E.; Ruddy, Kathryn J.; Unger, Paul S.; V...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 35(2021)
Page Start:
3938
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer. (23rd August 2018)

Authors:
Basho, Reva K.; Yam, Clinton; Gilcrease, Michael; Murthy, Rashmi K.; Helgason, Thorunn; Karp, Daniel D.; Meric‐Bernstam, Funda; Hess, Kenneth R.; Valero, Vicente; Albarracin, Constance; Litton, Jennifer K.; Chavez‐MacGregor, Mariana; Hong, David; Kurzrock, Razelle; Hortobagyi, Gabriel N.; Janku, ...
Journal:
Oncologist
Issue:
Volume 23:Number 11(2018)
Page Start:
1300
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Development of CNS metastases and survival in patients with inflammatory breast cancer. Issue 11 (26th March 2018)

Authors:
Uemura, Marc I.; French, John T.; Hess, Kenneth R.; Liu, Diane; Raghav, Kanwal; Hortobagyi, Gabriel N.; Arun, Banu K.; Valero, Vicente; Ueno, Naoto T.; Alvarez, Ricardo H.; Woodward, Wendy A.; Debeb, Bisrat G.; Moulder, Stacy L.; Lim, Bora; Tripathy, Debu; Ibrahim, Nuhad K.
Journal:
Cancer
Issue:
Volume 124:Issue 11(2018)
Page Start:
2299
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer. Issue 13 (26th March 2014)

Authors:
Murthy, Rashmi K.; Varma, Ankur; Mishra, Priyankana; Hess, Kenneth R.; Young, Elliana; Murray, James L.; Koenig, Kimberly H.; Moulder, Stacy L.; Melhem‐Bertrandt, Amal; Giordano, Sharon H.; Booser, Daniel; Valero, Vicente; Hortobagyi, Gabriel N.; Esteva, Francisco J.
Journal:
Cancer
Issue:
Volume 120:Issue 13(2014)
Page Start:
1932
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer. Issue 13 (26th March 2014)

Authors:
Murthy, Rashmi K.; Varma, Ankur; Mishra, Priyankana; Hess, Kenneth R.; Young, Elliana; Murray, James L.; Koenig, Kimberly H.; Moulder, Stacy L.; Melhem‐Bertrandt, Amal; Giordano, Sharon H.; Booser, Daniel; Valero, Vicente; Hortobagyi, Gabriel N.; Esteva, Francisco J.
Journal:
Cancer
Issue:
Volume 120:Issue 13(2014)
Page Start:
1932
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial. Issue 10 (1st April 2023)

Authors:
Speers, Corey W.; Symmans, W. Fraser; Barlow, William E.; Trevarton, Alex; The, Stephanie; Du, Lili; Rae, James M.; Shak, Steven; Baehner, Rick; Sharma, Priyanka; Pusztai, Lajos; Hortobagyi, Gabriel N.; Hayes, Daniel F.; Albain, Kathy S.; Godwin, Andrew; Thompson, Alastair
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 10(2023)
Page Start:
1841
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2. (24th January 2019)

Authors:
Prat, Aleix; Brase, Jan Christoph; Cheng, Yuan; Nuciforo, Paolo; Paré, Laia; Pascual, Tomás; Martínez, Débora; Galván, Patricia; Vidal, Maria; Adamo, Barbara; Hortobagyi, Gabriel N.; Baselga, José; Ciruelos, Eva
Journal:
Oncologist
Issue:
Volume 24:Number 7(2019)
Page Start:
893
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗